Related Experiment Video
Updated: Apr 17, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Impact of targeted PPARγ disruption on bone remodeling
Jay Cao1, Guomin Ou2, Nianlan Yang2
1USDA ARS Grand Forks Human Nutrition Research Center, Grand Forks, ND, United States.
Abstract:
Peroxisome proliferator-activated receptor gamma (PPARγ), known as the master regulator of adipogenesis, has been regarded as a promising target for new anti-osteoporosis therapy due to its role in regulating bone marrow mesenchymal stem/progenitor cell (BMSC) lineage commitment. However, the precise mechanism underlying PPARγ regulation of bone is not clear as a bone-specific PPARγ conditional knockout (cKO) study has not been conducted and evidence showed that deletion of PPARγ in other tissues also have profound effect on bone. In this study, we show that mice deficiency of PPARγ in cells expressing a 3.6 kb type I collagen promoter fragment (PPAR(fl/fl):Col3.6-Cre) exhibits a moderate, site-dependent bone mass phenotype. In vitro studies showed that adipogenesis is abolished completely and osteoblastogenesis increased significantly in both primary bone marrow culture and the BMSCs isolated from PPARγ cKO mice. Histology and histomorphometry studies revealed significant increases in the numbers of osteoblasts and surface in the PPARγ cKO mice. Finally, we found that neither the differentiation nor the function of osteoclasts was affected in the PPARγ cKO mice. Together, our studies indicate that PPARγ plays an important role in bone remodeling by increasing the abundance of osteoblasts for repair, but not during skeletal development.
Insights
Peroxisome proliferator-activated receptor gamma (PPARγ) deletion in bone cells increases osteoblasts, aiding bone repair. This study clarifies PPARγ’s role in bone remodeling, not skeletal development.
Area of Science:
- Bone Biology
- Stem Cell Biology
- Endocrinology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARγ) regulates adipogenesis and is a potential therapeutic target for osteoporosis.
- The exact role of PPARγ in bone regulation is unclear due to confounding effects from other tissues.
- A bone-specific PPARγ conditional knockout (cKO) model is needed to elucidate its precise function in bone.
Purpose of the Study:
- To investigate the specific role of PPARγ in bone biology using a bone-specific cKO mouse model.
- To determine the effect of PPARγ deletion on bone marrow mesenchymal stem/progenitor cell (BMSC) lineage commitment.
- To clarify the mechanism by which PPARγ influences bone remodeling and skeletal development.
Main Methods:
- Generated bone-specific PPARγ cKO mice (PPAR(fl/fl):Col3.6-Cre).
- Performed in vitro studies on primary bone marrow cultures and isolated BMSCs.
- Conducted histology and histomorphometry analyses on cKO mice.
- Assessed osteoclast differentiation and function.
Main Results:
- PPARγ cKO mice exhibited a moderate, site-dependent decrease in bone mass.
- In vitro, adipogenesis was abolished, and osteoblastogenesis was significantly increased in PPARγ-deficient cells.
- Histomorphometry revealed increased osteoblast numbers and surface in cKO mice.
- Osteoclast differentiation and function remained unaffected.
Conclusions:
- PPARγ plays a crucial role in bone remodeling by promoting osteoblast abundance for repair.
- PPARγ is not essential for skeletal development.
- Targeting PPARγ may offer a therapeutic strategy for bone repair in conditions like osteoporosis.
More Related Videos
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
TGF - β Signaling Pathway

